RESILIENCE helps you survive cancer with a strong heart

Príncipe de Asturias University Hospital joins the RESILIENCE project

We welcome Príncipe de Asturias University Hospital in Madrid, that has just joined the RESILIENCE project, together we will keep on working with the aim of helping people with cancer to live with a strong heart.

The Príncipe de Asturias University Hospital is located in the city of Alcalá de Henares and since its inauguration on 1987, the hospital has been adapting to continuous organizational and technological changes and the needs of a growing population. At present, the hospital has 507 beds with 39 different specialties and has earned recognized prestige among professionals and users. It develops a consolidated healthcare, research and teaching activity, for which it has the most modern technology and an excellent team of more than two thousand highly qualified professionals who have demonstrated their great professionalism and dedication to achieving high levels of quality and efficiency, offering quality specialized healthcare to its citizens who constitute the center of its activity and interest.

At the initial gathering held with the Hospital on December 11th, our RESILIENCE team shared the specifics of our clinical trial with Dr. Julio García Suarez and his team as well as the use of the Remote Ischemic Conditioning (RIC). The RIC is based on the positive effects that reversible episodes of occlusion and re-occlusion in the arm have on the heart, making it resistant to the damage of the chemotherapy treatment against cancer. With the use of the RIC, patients heart keeps being strong while at treatment and after it, turning away cardiovascular issues due to this treatment. The clinical trial RESILIENCE helps patients survive cancer with a strong heart.

Logotipo Resilience

Are you a patient participating in RESILIENCE? Here you will find useful information about the details of your participation, activities specifically designed for you. You will also be able to contact RESILIENCE researchers.

In accordance with the provisions of Regulation (EU) 2016/679 on the protection of personal data of natural persons (GDPR), the personal information you have provided will be incorporated into the data processing systems of the Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) for the purpose of attending your registration application in the restricted area for patients participating in the RESILIENCE study. The legal basis for processing your personal data for this purpose is your explicit consent. Your personal data will not be disclosed to any recipients other than those to whom you authorise or when required by law to do so. You may exercise your rights of access, right to rectification, to object, to erasure, to restriction of processing, data portability and not to be subject to automated individual decision-making. To exercise these rights, as well as to obtain additional information about the processing of your personal data, you can consult the following link Terms and Conditions